Greenwich LifeSciences Financial Overview
Greenwich LifeSciences's market cap is currently $156.14M. The company's EPS TTM is $-1.208; its P/E ratio is ―; Greenwich LifeSciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.